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Background & aims: Uncertainty still exists on the impact of low to moderate consumption of different drink types on population health. We therefore investigated the associations of different drink types in the form of beer/cider, champagne/white wine, red wine and spirits with various health outcomes. 
Methods: Over 500,000 participants were recruited to the UK Biobank cohort. Alcohol consumption was self-reported as pints beer/cider, glasses champagne/white wine, glasses of red wine, and measures of spirits per week. We followed health outcomes for a median of 7.02 years and reported all-cause mortality, cardiovascular events, ischemic heart disease, cerebrovascular events, and cancer. 
Results: In continuous analysis after excluding non-drinkers, beer/cider and spirits intake associated with an increased risk for all-cause mortality (beer/cider: hazard ratio, 1.56; 95% confidence interval, 1.45–1.68; spirits: 1.47;1.35–1.60), cardiovascular events (beer/cider: 1.25;1.17–1.33; spirits: 1.25;1.16–1.36), ischemic heart disease (beer/cider:1.12;0.99–1.26 [P=0.056]; spirits: 1.17;1.02–1.35), cerebrovascular disease (beer/cider: 1.63;1.32–2.02; spirits: 1.59;1.25–2.02) and cancer (beer/cider: 1.14;1.05–1.24; spirits: 1.14;1.03–1.26), while both champagne/white wine and red wine associated with a decreased risk for ischemic heart disease only (champagne/white wine: 0.84;0.72–0.98; red wine: 0.88;0.77–0.99). 
Conclusions: Our findings do not support the notion that alcohol from any drink type is beneficial to health. Consuming low levels of beer/cider and spirits already associated with an increased risk for all health outcomes, while wine showed opposite protective relationships only with ischemic heart disease. 





Alcohol is currently the top-grossing consumer goods category in the United Kingdom worth £16 billion [1]. At the same time, confusion still exists on the health impact of low to moderate alcohol consumption from different drink types  ADDIN EN.CITE [2-5]. This stems from studies reporting inconsistent findings from different population groups and study designs [6], but also from the subtle influence of the alcohol industry in science and public policy  ADDIN EN.CITE [7,8]. In addition, a systematic error exists in the literature caused by the inclusion of unhealthy non-drinkers in reference groups, giving rise to the J-shaped associations for alcohol-related health outcomes [9]. Over the past few decades, reporting on the protective effects of alcohol gained momentum, especially on cardiovascular risk, but oddly limited to coronary heart disease  ADDIN EN.CITE [10-12]. Some studies suggested that consuming alcohol three to seven days a week and even increasing daily alcohol intake by a moderate amount lowers risk of myocardial infarction  ADDIN EN.CITE [11,13]. The promotion of alcohol’s cardioprotective effects moved to drink types, expanding the scope from the more familiar red wine effects to beer and spirits  ADDIN EN.CITE [10,14-17]. Available evidence seems to support some cardioprotection from wine  ADDIN EN.CITE [18,19]. However, this also holds true for alcohol-free wine  ADDIN EN.CITE [20-23], raising the question whether we are in fact observing the protective effects of polyphenols rather than alcohol  ADDIN EN.CITE [18]. A second systematic error therefore looms, especially when studies quantify total alcohol consumption (e.g., as grams per day) without considering drink types, and consequently embedding the accompanying polyphenol effects of wine. 
Recent evidence raises concerns that even low to moderate alcohol consumption may not offer cardiovascular or cerebrovascular protection  ADDIN EN.CITE [4,24,25] and that besides alcohol’s known augmenting effects on blood pressure [26], the mechanism of iron loading may be involved in alcohol-induced pathology  ADDIN EN.CITE [27-29]. The Global Disease Burden Study 2016 concluded that no level of alcohol consumption mitigates adverse health outcomes, with increased consumption associating especially with all-cause mortality and cancer [5]. We investigated only in drinkers, independent of blood pressure, associations of drink types in the form of pints of beer/cider, glasses of champagne/white wine, glasses of red wine, and measures of spirits consumed per week with all-cause mortality, cardiovascular events, ischemic heart disease, cerebrovascular disease and cancer.
Materials and Methods
Study population 
The UK Biobank study involved a prospective cohort of 502,635 participants aged 40-69 years. The participants were recruited from primary care registers who attended one of 22 assessment centers across the UK between 2006 and 2010. Participants completed a detailed questionnaire using a touch-screen computer and provided sociodemographic, lifestyle and health information before undergoing physical and medical assessments  ADDIN EN.CITE [30]. The UK Biobank protocol complied with the World Medical Association Declaration of Helsinki of 1964 and its later amendments and was approved by the North West Multi-Centre Research Ethics Committee (MREC) and the Community Health Index Advisory Group (CHIAG). Participants provided informed consent on the touchscreen before taking part. The UK Biobank protocol is available online (http://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-Biobank-Protocol.pdf (​http:​/​​/​www.ukbiobank.ac.uk​/​wp-content​/​uploads​/​2011​/​11​/​UK-Biobank-Protocol.pdf​)). For the present analysis, we excluded participants that had a previous fatal or non-fatal cardiovascular event or previous cancer diagnosis (n=23 567). Since evidence exists that non-drinkers as reference group introduces a systematic error by being at higher risk than drinkers [9] and supported by our current analysis to be 24% (95% confidence interval, 13% to 36%) more likely to die from any cause and 29% (95% confidence interval, 19% to 40%) more likely to suffer a fatal or non-fatal cardiovascular event (CV events) compared to drinkers, we excluded 39,614 never drinkers and previous drinkers and limited our Cox regression analysis to 176,950 beer/cider drinkers, 183,930 champagne/white wine drinkers, 222,192 red wine drinkers, and 125,400 spirits drinkers. 
Measurements at baseline
Participants completed a touchscreen questionnaire including questions on sociodemographic characteristics, health status and lifestyle habits. Participants reported their smoking status and alcohol intake as never, previous or current. Intake of alcohol type was recorded as (1) average weekly pints (568 ml) of beer plus cider intake also including bitter, lager, stout, ale and/or Guinness; (2) average weekly glasses of champagne plus white wine intake with six 125 ml glasses per bottle as reference; (3) average weekly glasses of red wine intake with six 125 ml glasses per bottle as reference; and (4) average weekly measures of spirits such as whiskey, gin, rum, vodka or brandy, with 25 30 ml measures per normal 750 ml bottle as reference. As the definition of a standard drink varies from country to country, alcoholic beverage consumption was analyzed as glasses or measures per week. However, to convert to grams of pure ethanol consumed per week for ease of country-specific standard drink calculations, multiply the number of glasses/measures of beer/cider (4.5%), white wine/sparkling wine (11.5%), red wine (13%) and spirits (40%) by 20.17, 11.35, 12.82 and 7.89, respectively. A Townsend deprivation index was computed [31] for all participants using information about employment, car and home ownership and household overcrowding. The index was calculated immediately prior to participants joining the study based on the preceding national census output areas. Each participant was assigned a score corresponding to the output area in which their postcode is located. A higher Townsend deprivation index is indicative of greater levels of an area’s socioeconomic deprivation. 
Data on physical activity including frequency (number of days in a typical week that participants performed ten minutes or more of walking, moderate and vigorous physical activity) and duration (minutes spent on each activity category on a typical day) were collected by asking questions similar to those included in the International Physical Activity Questionnaire  ADDIN EN.CITE [32]. For each activity category, the frequency was multiplied by the duration and the metabolic equivalent (MET) value (3.3 for walking, 4.0 for moderate physical activity and 8.0 for vigorous physical activity), which were then summed to generate a score of MET-minutes of physical activity per week for each participant  ADDIN EN.CITE [32]. Participants were interviewed by a trained research nurse to determine whether they have previously been diagnosed with any medical conditions.
Height was measured using the SECA 240 height measure (SECA, Hamburg, Germany). Body mass was measured to the nearest 0.1 kg using a segmental body composition analyzer (Tanita BC-418MA, Tokyo, Japan) and body mass index calculated as weight (kg) divided by height squared (m2).
Blood pressure was measured in duplicate, one minute apart, using the OMRON hem-7015IT digital blood pressure monitor. Liver MRI measurements were performed using the Siemens 1.5 MAGNETOM Aera and derived measures of liver content generated by Perspectrum Diagnostics. Liver iron content (mg/g dry weight tissue) was estimated from T2 according to a previously determined model [33].
Assessment of outcome
We obtained the health outcomes of each participant through linkage with the Health and Social Care Information Centre for English and Welsh participants and the Information Services Department for Scottish participants and ascertained all-cause mortality and the diagnoses of incident fatal and non-fatal cardiovascular (CV) events (International Classification of Diseases 10th Revision [ICD10]: I00-I99), ischemic heart disease (ICD10: I20-I25), cerebrovascular disease (ICD10: I60-I69) and cancer as all malignant neoplasms (ICD: C00-C97) until 31 January 2016 for England and Wales and 30 November 2015 for Scotland. The first event from baseline was used in the survival analysis. Primary care physicians confirmed the diagnoses of all events. 
Statistical analysis 
For database management and statistical analysis, we used SAS software, version 9.4 (SAS Institute Inc., Cary, NC). We compared means and proportions by the t-test and the 2 statistic, respectively, and survival curves by Kaplan-Meier survival function estimates and the log-rank test. Statistical significance was set at a level of 0.05 on 2-sided tests. 
Using the forward stepwise procedure, we analyzed associations between drink types and health outcomes by means of both categorical and continuous analysis. In categorical analysis using Cox proportional hazard regression analyses, drink types were categorized into 1-7, 8-14, 15-21, and >21 pints of beer/cider, glasses of champagne/white wine, glasses of red wine or measures of spirits per week using other drinkers that do not drink the type of drink as reference group, e.g., comparing beer drinkers to champagne/white wine, red wine and spirits drinkers combined as reference group. In addition, the risk associated with the four drink types as number of pints, glasses or measures per week were analyzed in a continuous manner as discrete variables without the use of a reference group. All models included baseline age, body mass index, sex, smoking, systolic blood pressure, physical activity, diabetes and Townsend deprivation index as covariables or potential confounders. We checked the proportional hazards assumption by the Kolmogorov-type supremum test, as implemented in the PROC PHREG procedure of the SAS package. We tested heterogeneity in the hazard ratios across gender by introducing the appropriate interaction term in the Cox models. Lastly, we performed multiple regression analyses to assess associations between MRI-derived liver iron content and the different drink types while adjusting for sex, age and body mass index.
Results
Table 1 provides the baseline characteristics for 446439 current drinkers. Median follow-up was 7.05 years (5th to 95th percentile interval, 5.70 to 8.43 years) for all-cause mortality, 7.01 years (5th to 95th percentile interval, 5.61 to 8.41 years) for CV events and 6.86 years (5th to 95th percentile interval, 5.68 to 8.43 years) for cancer. There were 31,396, 24,324, 29,486 and 8,669 participants that only drank beer/cider, champagne/white, red wine and spirits, but 176,950, 183,930, 222,192 and 125,400 participants, respectively, that drank beer/cider, champagne/white, red wine and spirits, but also a combination thereof. All further analysis was based on the latter groups. 
In unadjusted analyses of Kaplan Meier estimates, the log-rank test was significant for all-cause mortality, CV events (both p<0.0001, Fig. 1), ischemic heart disease (p<0.0001, Supplemental Fig. 1), and cerebrovascular disease (p<0.0001, Supplemental Fig. 2), and borderline significant for cancer (P=0.099, Supplemental Fig. 3) across drink types. The sex- and age-standardized rates increased for all-cause mortality (p-trend <0.0001), CV events (p-trend <0.0001, Fig. 2, Supplemental Table 1), ischemic heart disease (p-trend <0.0001) and cerebrovascular disease (p-trend <0.0001) across quartiles of weekly beer/cider and spirits intake (Supplemental Table 1), and for cancer across quartiles of spirits intake (p-trend <0.0001; Supplemental Table 1), but not for any outcome measures across quartiles of weekly glasses of champagne/white wine (p-trend ≥0.25) or red wine (p-trend ≥0.19). The number of pints, glasses or measures of beer/cider, champagne/white wine, red wine and spirits consumed per week all fulfilled the proportional hazards assumption for all-cause mortality (p≥0.058), CV events (p≥0.19), ischemic heart disease (p≥0.88), cerebrovascular disease (p≥0.33) and cancer (p≥0.24). 
The multivariable-adjusted hazard ratios by drink type stratified by 1-7, 8-4, 15-21 and >21 pints, glasses or measures per week are presented in Fig. 3 and Supplemental Table 2 and 3. Compared with all other alcohol type drinkers as reference, an increase in beer consumption associated with an increased risk for all outcome measures (p-trend ≤0.019), while spirits consumption associated with all-cause mortality (p-trend <0.0001), CV events (p-trend <0.0001), cerebrovascular disease (p-trend=0.004) and was borderline significant for cancer (p-trend=0.079). Consumption of champagne/white wine and red wine associated with a decreased risk for all-cause mortality, CV events and ischemic heart disease (all p-trend <0.0001), while red wine was also inversely associated with cerebrovascular disease (p-trend=0.0003).
In continuous analysis, using number of pints, glasses or measures in the models (Table 2, Supplemental Fig. 4, Supplemental Tables 4 and 5), weekly intake of pints of beer/cider and measures of spirits associated with an increased risk for all-cause mortality (both, p<0.0001), CV events (both p<0.0001), ischemic heart disease (beer/cider, p=0.056; spirits, p=0.027), cerebrovascular disease (both, p≤0.0002), and cancer (beer/cider, p=0.002; spirits, p=0.011). The inverse association for champagne/white wine and red wine observed in the categorical analyses above largely disappeared in continuous analysis, however remained for ischemic heart disease (champagne/white wine, p=0.028; red wine, p=0.044). 
To account for imbalances in type of drink consumed as a source of bias, e.g., one individual being a low-level consumer of beer, but high-level wine consumer, we additionally adjusted for total alcohol consumption in grams per week. By doing so, we could confirm our findings (Supplemental Table 6). In addition, beer/cider associated with an increased risk for ischemic heart disease (hazard ratio, 1.36, 95% confidence interval, 1.16–1.60), while champagne/white wine associated inversely with cancer (hazard ratio, 0.90, 95% confidence interval, 0.81–0.99; p=0.043) and red wine with both all-cause mortality (hazard ratio, 0.81, 95% confidence interval, 0.73–0.89; p<0.0001) and cerebrovascular disease (hazard ratio, 0.67, 95% confidence interval, 0.51–0.87; p=0.003). 
In continuous analysis, we analyzed the risk associated with single increments per week of pints, glasses and measures (Supplemental Tables 7 and 8). Beer/cider consumption associated with an increased risk for all-cause mortality at 6 pints per week, CV events at 2 pints per week, cerebrovascular disease at 5 pints per week and cancer at 11 pints per week. Spirits consumption associated with all outcome measures, i.e., at 7, 6, 12, 13, and 8 measures per week for all-cause mortality, CV events, ischemic heart disease, cerebrovascular disease and cancer, respectively. Champagne/white wine associated with a decreased risk for all-cause mortality and CV events only when consuming 4-5 glasses per week, while a more consistent inverse relationship existed with ischemic heart disease when 4 glasses or more per week were consumed. Red wine associated with a decreased risk of ischemic heart disease when weekly consumption was between 8 and 11 glasses.
In line with the alcohol-induced iron loading hypothesis  ADDIN EN.CITE [27-29], MRI-derived liver iron content, reflective of iron loading [34], correlated with drink types in a sub-sample of 1014 participants. After accounting for age, sex and body mass index in multiple regression analysis, the consumption of beer/cider associated with a 0.022 mg/g (95% confidence interval, –0.002 to 0.046 mg/g; p=0.069) increase in liver iron per pint consumed per week, 0.035 mg/g (95% confidence interval, 0.012 to 0.058 mg/g; p=0.003) increase per glass champagne/white wine, 0.042 mg/g (95% confidence interval, 0.022 to 0.062 mg/g; p<0.0001) increase per glass red wine and 0.036 mg/g (95% confidence interval, 0.006 to 0.065 mg/g; p=0.020) increase per measure spirits.
Discussion
We investigated the risk associated with drink types in a large population of alcohol consumers. We found that (1) even low-level consumption of beer/cider and spirits associated with an increased risk of all-cause mortality, CV events, ischemic heart disease (borderline significant for beer/cider), cerebrovascular disease and cancer; (2) champagne/white wine and red wine associated with a decreased risk for ischemic heart disease only; and (3) liver iron content increased with increased consumption of all drink types, supporting the iron-loading effect of alcohol.
At first glance, the literature supporting the beneficial effects of low to moderate alcohol consumption, especially on cardiovascular disease, seems plausible. However, most of this evidence have three commonalities, i.e., (1) coronary heart disease as outcome measure, (2) non-drinkers as reference group, and (3) not considering drink types. In a systematic review involving ten observational studies, the authors concluded that all alcoholic drinks were linked to a lower coronary heart disease risk and that a substantial portion of the benefit was from alcohol rather than other non-alcohol components of wine, beer or spirits [10]. Similarly, in a meta-analysis involving 12 cohort and two case-control studies, Cleophas [14] found that ‘small doses’ of alcohol intake (1-4 drinks per day) associated with a reduced risk of all-cause mortality and coronary heart disease and that wine, beer, and spirits were equally beneficial. In another meta-analysis involving 176,042 participants from 10 studies, Di Castelnuovo supported the inverse relationship between wine and beer and vascular risk [15], but in a different study nine years later still failed to show any inverse protective relationship for spirits [17]. In a study involving 38,077 men from the Health Professionals Follow-Up Study, a 12.5 g increase in daily alcohol consumption over a four-year follow-up period associated with a 22% reduced risk of a myocardial infarction compared to men who consumed alcohol less than once per week, or effectively non-drinkers [11]. In addition, drinkers reporting consumption of alcohol at least 3-4 days per week had a reduced risk of myocardial infarction, with this association presumably unaltered by the type of beverage consumed [11]. Pooling 32,826 women from the Nurses Health Study and 18,225 men from the Health Professionals Follow-Up Study, the same authors found an inverse association between frequency of consumption (days per week) and myocardial infarction in men and women compared to non-drinkers [13]. The latest evidence comes from the Million Veteran Program study in 156,728 participants, again using coronary artery disease as outcome measure and never-drinkers as reference group  ADDIN EN.CITE [12]. Consuming more than 3 to 4 drinks per day associated with a 42% reduction in coronary heart disease risk and in additional analysis, consuming 24-48 g ethanol for 6-7 days a week (which equates to ~9 to 18 pints of 4% beer per week), associated with a 41% reduction, while beverage preference was reported to not affect their findings  ADDIN EN.CITE [12].
The above evidence with the use of non-drinkers as reference group and therefore introducing the systematic error [9], and by focusing only on coronary heart disease, detracts from the true and overall health effects of alcohol  ADDIN EN.CITE [3,4]. Globally, the health burden of alcohol use looks dire. The Global Burden of Diseases, Injuries, and Risk Factors Study involving 195 countries and territories suggests that alcohol use is a leading risk factor for disease burden [5]. By capturing alcohol consumption as grams of pure ethanol consumed daily, some protective evidence did exist for ischemic heart disease for men (14% reduced risk at 0.83 standard drinks daily) and women (18% reduced risk at 0.92 standard drinks daily). However, these associations were offset when considering overall health risks, especially from cancer, and was not supportive of any level of consumption being beneficial [5]. The CALIBER study  ADDIN EN.CITE [35] involving 1,937,360 adults showed that compared with moderate drinkers, heavy drinking (defined as combining “alcohol intake above recommended sensible drinking limits” and “hazardous alcohol use”) associated with a reduced risk of myocardial infarction (12%) and stable angina (7%), but was associated with an increased risk of all other cardiovascular and cerebrovascular outcomes. Finally, supporting our findings and our suggestion of a second systematic error, comes from the EPIC-CVD study  ADDIN EN.CITE [2]. Compared to 0.1-4.9 grams per day alcohol intake, increased daily alcohol consumption associated with a reduced risk for coronary heart disease, but increased risk for stroke (≥60 grams per day only). When performing the analyses separately for alcohol obtained from wine and beer, ‘alcohol’ from wine associated with a reduced risk for coronary heart disease, while beer associated with an increased risk for stroke  ADDIN EN.CITE [2]. Our results support this favorable relationship between wine and coronary artery disease, but this may rather be due to the polyphenol content in wine that seems observable at the coronary arteries in cohort studies. The increased risk associated with beer containing only low level-level polyphenols and spirits containing no polyphenols supports this. 
There is a poor understanding of the mechanisms at work. Evidence for the relationship with coronary artery disease does lean towards the anti-oxidant effects of polyphenols in wine  ADDIN EN.CITE [6,18]. The protective effect also seen for alcohol-free wine supports this  ADDIN EN.CITE [19-23], but then at least in part, discredits the beneficial effect of alcohol. Alcohol is known to increase blood pressure [26] and believed to explain alcohol’s relationship with cardiovascular morbidity and mortality  ADDIN EN.CITE [25]. However, our findings were independent of blood pressure and along with the known relationship between alcohol and cancer [36], suggests other mechanisms such as oxidative stress from alcohol-induced iron loading may be at work  ADDIN EN.CITE [28,29]. We recently investigated the concept of iron loading in 877 African women and found that, apart from serum ferritin as marker of systemic iron loading associating with cardiovascular mortality, the level of iron loading was dependent on alcohol intake  ADDIN EN.CITE [27]. Systemic iron is tightly regulated and toxic in excessive amounts causing oxidative stress by producing especially harmful hydroxyl radicals through the Fenton reaction [37]. Hepcidin, the systemic iron regulatory hormone produced in the liver, prevents iron loading  ADDIN EN.CITE [38,39] by triggering the internalization, ubiquitination and degradation of the iron exporter ferroportin in enterocytes, hepatocytes and macrophages  ADDIN EN.CITE [40,41]. However, alcohol suppresses hepcidin production which compromises this defense  ADDIN EN.CITE [42,43]. Although iron loading is common in alcoholic liver disease [44], moderate consumption of more than two drinks a day could already cause iron loading [29]. In our current sub-sample analyses, the positive associations obtained between MRI-derived liver iron content and drink types support this alcohol-induced iron-loading hypothesis.
In the United Kingdom, the Chief Medical Officer recommends not to drink more than 14 units a week on a regular basis [45]. This equates to seven pints of average-strength (4%) lager, around nine glasses of 125 ml wine (alcohol by volume, 12%), and 14 single measure of spirits (alcohol by volume, 37.5%). Our findings support the growing body of evidence questioning beneficial effects from any level of alcohol intake. We also propose a second systematic error resulting from the embedment of the polyphenol effects of wine  ADDIN EN.CITE [18] when capturing total alcohol consumption. 
The current study must be interpreted within the context of its potential strengths and limitations. Strengths of our study include its prospective study design and the large sample of alcohol consumers. Our analysis included a large number of incident fatal and non-fatal events and controlled for various covariables and potential confounders. We did not base our main findings on analyses using reference groups, but mainly performed continuous analysis to limit bias [9]. The response rate of the UK Biobank was 5.5% with evidence of a ‘healthy volunteer’ selection bias  ADDIN EN.CITE [46]. However, in line with the study design of the UK Biobank study, we were still able to investigate exposure-disease associations which is still widely generalizable and does not necessarily require participants to be representative of the population at large [47]. Alcohol consumption was self-reported as average weekly intake and we cannot exclude the possibility of recall bias. Although we applied adjustments in our regression models, the possibility of residual confounding still exists. We used the Townsend deprivation index as a measure of deprivation which does not indicate the proportion of people in an area who are deprived, and therefore a potential risk of ecological fallacy exists.
In conclusion, our findings do not support the notion that alcohol consumption is beneficial to health. Consumption of even low amounts of beer/cider and spirits were associated with all-cause mortality, CV events, ischemic heart disease, cerebrovascular disease and cancer. Wine consumption showed beneficial relationships with ischemic heart disease only; however, this observation seems more likely due to the properties of polyphenols rather than wine’s alcoholic content. Iron-loading resulting from alcohol consumption may contribute to the associations between alcohol intake and health risk in the general population, although this requires further investigation. 
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Fig. 1 Kaplan-Meier survival function estimates in all drinkers for (a) all-cause mortality and (b) cardiovascular (CV) events by the weekly number of pints of beer or cider, glasses of champagne or white wine, glasses of red wine and measures of spirits. P values refer to the significance of the log-rank test.
Fig. 2 All-cause mortality (a) and cardiovascular (CV) events (b) by quartiles of the distribution of the weekly number of pints of beer or cider, glasses of champagne or white wine, glasses of red wine and measures of spirits. Incidence rates were standardized for sex and age by the direct method. The number of endpoints contributing to the rates is presented. The trend across quartiles of weekly number of pints of beer or cider and measures of spirits were significant for all-cause mortality (both P<0.0001) and cardiovascular (CV) events (both P<0.0001). The trends across quartiles of glasses of champagne or white wine and glasses of red wine were all non-significant (P≥0.32). To convert to grams of pure ethanol consumed per week, multiply number of pints of beer or cider, glasses of champagne or white wine, glasses of red wine and measures of spirits by 20.17, 11.35, 12.82 and 7.89, respectively.





Table 1 Participant characteristics for 446439 current drinkers
Characteristics	Current drinkers
n	446439
Women n (%)	240351 (53.8)
Age (years)	56.4±8.1
Body mass index (kg/m2)	27.3±4.7
Systolic blood pressure (mmHg)	139.8±19.7
Diastolic blood pressure (mmHg)	82.3±10.7
Physical Activity (MET-minutes/week)	1052 (146-6318)
Current smoking n (%) 	47091 (10.5)
Townsend deprivation index	–1.42 (3.02)
Diabetes n (%)	20809 (4.7)
All-cause mortality n (%)	12626 (2.8)
Fatal and non-fatal CV events n (%)	15689 (3.5)
Ischemic heart disease n (%)	4659 (1.0)
Cerebrovascular disease n (%)	1576 (0.4)
Cancer n (%)	16399 (3.7)






Table 2 Unadjusted and adjusted hazard ratios for number of weekly pints, glasses or measures of beer/cider, champagne/white wine, red wine and spirits as continuous variables
Reference	All-cause mortality	Cardiovascular events	Ischemic heart disease	Cerebrovascular disease	Cancer
Beer/cider (n, 176950)					
Number of cases	5646	7149	2369	678	6277
Unadjusted HR (95% CI)	1.35 (1.32–1.39)§	1.21 (1.19–1.24)§	1.26 (1.21–1.31)§	1.32 (1.22–1.42)§	1.07 (1.04–1.11)§
Adjusted HR (95% CI)	1.56 (1.45–1.68)§	1.25 (1.17–1.33)§	1.12 (0.99–1.26)	1.63 (1.32–2.02)§	1.14 (1.05–1.24)†
Champ/w.wine (n, 183930)					
Number of cases	4092	5389	1439	540	6635
Unadjusted HR (95% CI)	0.98 (0.95–1.01)	0.96 (0.93–0.98)†	0.90 (0.85–0.94)§	0.97 (0.89–1.05)	0.98 (0.95–1.02)
Adjusted HR (95% CI)	1.04 (0.95–1.14)	0.97 (0.90–1.05)	0.84 (0.72–0.98)*	0.94 (0.73–1.20)	0.98 (0.89–1.07)
Red wine (n, 222192)					
Number of cases	5260	7066	2019	694	8069
Unadjusted HR (95% CI)	1.04 (1.01–1.07)†	1.05 (1.03–1.08)§	1.04 (0.99–1.09)	1.02 (0.94–1.10)	1.03 (0.99–1.06)
Adjusted HR (95% CI)	0.95 (0.88–1.03)	0.98 (0.92–1.05)	0.88 (0.77–0.99)*	0.89 (0.72–1.11)	1.02 (0.94–1.11)
Spirits (n, 125400)					
Number of cases	3958	4868	1476	511	4860
Unadjusted HR (95% CI)	1.36 (1.32–1.40)§	1.21 (1.18–1.24)§	1.26 (1.20–1.32)§	1.37 (1.27–1.48)§	1.11 (1.07–1.14)§
Adjusted HR (95% CI)	1.47 (1.35–1.60)§	1.25 (1.16–1.36)§	1.17 (1.02–1.35)*	1.59 (1.25–2.02)‡	1.14 (1.03–1.26)*
The Cox models included baseline age, body mass index, sex, smoking, systolic blood pressure, physical activity, diabetes and Townsend deprivation index. Hazard ratios are given with 95% confidence intervals. Significance of the hazard ratios: * p<0.05; † p<0.01; ‡ p<0.001; and § p<0.0001
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